Elmind Capital »

Beam Therapeutics shares owned by Elmind Capital

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 476k 23.83

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Beam Therapeutics

ARK Investment Management
FMR
Farallon Capital Management
Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Arch Venture Corp
Vanguard Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
Geode Capital Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics